AKBA

Akebia Therapeutics, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$188.33 sample

-0.92 (-0.49%) 1D

Market cap

$878.7B

Price as of

2026-10-04

Latest filing

8-K

Alerts

8

Price$188.33 +2.57% 3M daily closessample

193.66180.20

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider buy: 10% owner
Sep 21INSInsider sell: Chief Financial Officer
Sep 16INSInsider buy: Chief Financial Officer
Sep 09INSInsider sell: EVP, Operations
Aug 31INSInsider sell: General Counsel
Aug 20INSInsider sell: Chief Financial Officer
Aug 12INSInsider sell: Chief Executive Officer
Aug 07INSInsider sell: 10% owner

Sign up to see the real AKBA record →

Company facts

SEC EDGAR registration

Name: Akebia Therapeutics, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: +21sample, -100 to +100
Reporting currency: USD

Who is positioning in AKBA

sample

Insiders: 27 insider transactions over 90 days, net selling, $749.2M
Congress: No member trades over 90 days
Institutions · 13F: 38 funds hold $20.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$20.3B +17.7% y/y

Q4 2024Q3 2026

Inventory$12.3B +15.8% y/y

Q4 2024Q3 2026

Accounts receivable$9.3B +14.7% y/y

Q4 2024Q3 2026

Total debt$24.6B +14.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $674.8B +10.2% 3M
Sample peer B: $848.9B -11.4% 3M
Sample peer C: $851.3B +5.5% 3M
Sample peer D: $427.0B -1.1% 3M
Sample peer E: $394.0B -12.1% 3M